Can Fosfomycin and Levofloxacin Be Taken Together?
Yes, fosfomycin and levofloxacin (Levaquin) can be taken together safely—there are no known drug-drug interactions between these two antibiotics, and they are actually used in combination for certain resistant infections.
Drug Interaction Profile
The FDA drug labels for both medications do not list any interactions between fosfomycin and levofloxacin 1. Levofloxacin's documented interactions include:
- Divalent cations (antacids, iron, multivitamins with zinc) - must be separated by 2 hours
- Warfarin - requires INR monitoring
- NSAIDs - increased seizure risk
- Theophylline - monitor levels closely
Fosfomycin has minimal drug interactions and is primarily renally excreted 2.
Evidence for Combination Use
Combination therapy is actually supported in specific clinical scenarios:
For Carbapenem-Resistant Infections
Recent guidelines explicitly recommend fosfomycin-containing combination therapies for carbapenem-resistant Enterobacteriaceae (CRE) infections when the isolate is susceptible to fosfomycin 3. While these guidelines specifically mention combinations with tigecycline, polymyxins, and carbapenems, the principle of fosfomycin combination therapy is well-established.
For Pseudomonas Infections
Research demonstrates synergistic effects when fosfomycin is combined with fluoroquinolones (including levofloxacin) against Pseudomonas aeruginosa, particularly in biofilm-associated infections 4, 5, 6. One study showed that fosfomycin combined with levofloxacin had an efficacy rate of 66.7% against multidrug-resistant P. aeruginosa 5.
For Complicated UTIs
A 2023 clinical trial directly compared daily fosfomycin versus levofloxacin for complicated urinary tract infections, demonstrating comparable clinical cure rates 7. While this was a comparison study rather than combination therapy, it confirms both agents are appropriate for similar indications without safety concerns when used together.
Clinical Considerations
When combination therapy makes sense:
- Severe infections requiring broad-spectrum coverage
- Multidrug-resistant organisms (particularly CRE or MDR Pseudomonas)
- Biofilm-associated infections (e.g., catheter-related UTIs)
- Step-down therapy where one agent provides IV coverage and the other oral coverage
Important caveats:
- Fosfomycin should be confirmed susceptible via antimicrobial susceptibility testing before use in combination therapy 3
- Both drugs require renal dose adjustment in severe renal impairment (CrCl <30 mL/min for levofloxacin; avoid fosfomycin in severe renal impairment) 8, 2
- Levofloxacin carries black box warnings for tendon rupture, peripheral neuropathy, and CNS effects
- Therapeutic drug monitoring should be considered for levofloxacin in severe infections 3
Common pitfall: Using fluoroquinolones unnecessarily when narrower-spectrum agents would suffice. Reserve levofloxacin for resistant organisms or when first-line agents cannot be used 8, 9, 10.
The combination is pharmacologically safe and may provide synergistic antimicrobial activity, particularly against resistant Gram-negative pathogens.